С Википедије, слободне енциклопедије
Naltrekson Prodajno ime Celupan, MorViva, N-Cyclopropylmethylnoroxymorphone, Naltrexona [INN-Spanish] Drugs.com Monografija Način primene Oralno Poluvreme eliminacije 4 h Izlučivanje Renalno
CAS broj 16590-41-3 Y ATC kod N07BB04 (WHO PubChem CID 5360515 DrugBank DB00704 Y ChemSpider 4514524 Y KEGG C07253 Y ChEBI CHEBI:7465 Y ChEMBL CHEMBL142 Y Formula C 20 H 23 N O 4 Molarna masa 341,401
[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O
InChI=1S/C20H23NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,15,18,22,24H,1-2,5-10H2/t15-,18+,19+,20-/m1/s1
Y Key:DQCKKXVULJGBQN-XFWGSAIBSA-N
Y
Tačka topljenja
Naltrekson je organsko jedinjenje , koje sadrži 20 atoma ugljenika i ima molekulsku masu od 341,401 Da .[1] [2] [3] [4] [5]
^ Schmitz JM, Stotts AL, Rhoades HM, Grabowski J: Naltrexone and relapse prevention treatment for cocaine-dependent patients. Addict Behav. 2001 Mar-Apr;26(2):167-80. PMID 11316375
^ Krystal JH, Gueorguieva R, Cramer J, Collins J, Rosenheck R: Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, Naltrexone in the treatment of alcoholism. Alcohol Clin Exp Res. 2008 Jan;32(1):85-91. Epub 2007 Dec 7. PMID 18070245
^ Ray LA, Chin PF, Miotto K: Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics. CNS Neurol Disord Drug Targets. 2010 Mar;9(1):13-22. PMID 20201811
^ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs” . Nucleic Acids Res . 39 (Database issue): D1035—41. PMC 3013709 PMID 21059682 . doi :10.1093/nar/gkq1126 . уреди ^ David S. Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets” . Nucleic acids research . 36 (Database issue): D901—6. PMC 2238889 PMID 18048412 . doi :10.1093/nar/gkm958 . уреди ^ Ghose, A.K.; Viswanadhan V.N. & Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods” . J. Phys. Chem. A . 102 : 3762—3772. doi :10.1021/jp980230o . ^ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices” . Chem Inf. Comput. Sci . 41 : 1488—1493. PMID 11749573 . doi :10.1021/ci000392t . уреди ^ Ertl P.; Rohde B.; Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties” . J. Med. Chem . 43 : 3714—3717. PMID 11020286 . doi :10.1021/jm000942e . уреди
Molimo Vas, obratite pažnju na važno upozorenje oblasti medicine (zdravlja) .
. PMID 21059682. doi:10.1093/nar/gkq1126.
